Zai Lab
ZLAB
$16.25
Share price
-2.05%
Change (1 day)
-56.84%
Change (1 year)
Categories
Zai Lab (ZLAB) - P/B ratio
P/B ratio as of May 2024 : 2.13
According to Zai Lab's latest financial reports the company has a price-to-book ratio of 2.13.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Zai Lab - P/B ratio (from 2017 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.39 | 12.79% |
| 2022-12-31 | 3.01 | -33.64% |
| 2021-12-31 | 4.53 | -54.78% |
| 2020-12-31 | 10.0 | 3.88% |
| 2019-12-31 | 9.65 | 78.83% |
| 2018-12-31 | 5.40 | 21.25% |
| 2017-12-31 | 4.45 | |
| 2016-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6522 | -69.40% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -8.10% | 🇺🇸 USA |